Re:NewCell AB (publ)
SSE:RENEW.ST
5 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 84.4 | 84.8 | 29.7 | 6.283 | 3.031 | 2.457 | 2.033 | 2.108 | 0.636 | 0.228 | 0.601 | 0.232 | 0.328 | 0.868 | 0.024 | 0.508 |
| Cost of Revenue
| 85.8 | 94.2 | 54.9 | 53.354 | 9.604 | 9.314 | 10.008 | 9.972 | 1.519 | 2.38 | 1.979 | 2.486 | 0.7 | 2.701 | 1.723 | 3.672 |
| Gross Profit
| -1.4 | -9.4 | -25.2 | -47.071 | -6.573 | -6.857 | -7.975 | -7.864 | -0.883 | -2.152 | -1.378 | -2.254 | -0.372 | -1.833 | -1.699 | -3.164 |
| Gross Profit Ratio
| -0.017 | -0.111 | -0.848 | -7.492 | -2.169 | -2.791 | -3.923 | -3.731 | -1.388 | -9.439 | -2.293 | -9.716 | -1.134 | -2.112 | -70.792 | -6.228 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 3.101 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 24.3 | -24.364 | 23.351 | 20.435 | 17.179 | 10.435 | 11.882 | 9.683 | 9.456 | 6.125 | 8.447 | 8.96 | 8.62 | -0.828 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 10.167 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0 | 0.2 | 24.3 | -14.197 | 23.351 | 20.435 | 17.179 | 10.435 | 11.882 | 9.683 | 9.456 | 6.125 | 8.447 | 8.96 | 8.62 | -0.828 |
| Other Expenses
| 0.2 | 1.2 | 56.1 | 66.721 | 31.047 | 29.723 | 23.615 | 42.996 | 12.512 | 10.68 | 8.796 | 12.576 | 6.947 | 5.206 | 5.519 | 9.722 |
| Operating Expenses
| 75.9 | 76.4 | 80.4 | 52.524 | 54.398 | 50.158 | 40.794 | 53.431 | 24.394 | 20.363 | 18.252 | 18.701 | 15.394 | 14.166 | 14.139 | 8.894 |
| Operating Income
| -75.8 | -84.6 | -105.7 | -96.237 | -60.971 | -57.015 | -48.767 | -60.892 | -25.277 | -22.516 | -19.63 | -20.955 | -15.766 | -15.728 | -15.837 | -12.057 |
| Operating Income Ratio
| -0.898 | -0.998 | -3.559 | -15.317 | -20.116 | -23.205 | -23.988 | -28.886 | -39.744 | -98.754 | -32.662 | -90.323 | -48.067 | -18.12 | -659.875 | -23.734 |
| Total Other Income Expenses Net
| -19.2 | -21.2 | -20 | 20.192 | -40.501 | -11.388 | -5.248 | -5.321 | 0.739 | -0.902 | 0.381 | -0.117 | -0.11 | -0.091 | -0.119 | -0.126 |
| Income Before Tax
| -95 | -105.8 | -125.7 | -76.045 | -101.472 | -68.403 | -54.015 | -66.226 | -24.538 | -23.417 | -19.249 | -21.072 | -15.876 | -16.09 | -15.957 | -12.184 |
| Income Before Tax Ratio
| -1.126 | -1.248 | -4.232 | -12.103 | -33.478 | -27.84 | -26.569 | -31.417 | -38.582 | -102.706 | -32.028 | -90.828 | -48.402 | -18.537 | -664.875 | -23.984 |
| Income Tax Expense
| -0.4 | -0.4 | -0.4 | 0.002 | 40.501 | 11.388 | -0.001 | 5.32 | 0.803 | -0.831 | 0.468 | 0.021 | 0.001 | -0.271 | -0.001 | -0.001 |
| Net Income
| -94.5 | -105.4 | -125.3 | -76.047 | -141.973 | -79.791 | -54.014 | -66.225 | -24.538 | -23.417 | -19.25 | -21.071 | -15.877 | -15.819 | -15.956 | -12.183 |
| Net Income Ratio
| -1.12 | -1.243 | -4.219 | -12.104 | -46.84 | -32.475 | -26.569 | -31.416 | -38.582 | -102.706 | -32.03 | -90.823 | -48.405 | -18.225 | -664.833 | -23.982 |
| EPS
| -2.31 | -2.82 | -3.35 | -2.1 | -4.18 | -2.44 | -1.75 | -2.15 | -0.8 | -0.76 | -0.63 | -0.68 | -0.52 | -0.51 | -0.52 | -0.4 |
| EPS Diluted
| -2.26 | -2.72 | -3.24 | -2.05 | -4.01 | -2.34 | -1.67 | -2.05 | -0.76 | -0.72 | -0.6 | -0.68 | -0.52 | -0.51 | -0.52 | -0.4 |
| EBITDA
| -49.2 | -58.5 | -80.3 | -93.376 | -58.228 | -54.411 | -44.283 | -58.828 | -22.551 | -21.491 | -17.36 | -19.19 | -14.011 | -14.262 | -14.116 | -10.106 |
| EBITDA Ratio
| -0.583 | -0.69 | -2.704 | -14.862 | -19.211 | -22.145 | -21.782 | -27.907 | -35.458 | -94.259 | -28.885 | -82.716 | -42.716 | -16.431 | -588.167 | -19.894 |